NRX Pharmaceuticals
NRXP
NRXP
31 hedge funds and large institutions have $1.76M invested in NRX Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
5% less capital invested
Capital invested by funds: $1.86M → $1.76M (-$97.1K)
67% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 9
Holders
31
Holding in Top 10
–
Calls
$41K
Puts
$5K
Top Buyers
| 1 | +$18.6K | |
| 2 | +$13.1K | |
| 3 | +$3.79K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$816 |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$52 |
Top Sellers
| 1 | -$23K | |
| 2 | -$21.1K | |
| 3 | -$14.3K | |
| 4 |
HSA
HBK Sorce Advisory
Erie,
Pennsylvania
|
-$13.4K |
| 5 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
-$13.1K |